AU5636896A - Inhibition of intracellular acidification - Google Patents

Inhibition of intracellular acidification

Info

Publication number
AU5636896A
AU5636896A AU56368/96A AU5636896A AU5636896A AU 5636896 A AU5636896 A AU 5636896A AU 56368/96 A AU56368/96 A AU 56368/96A AU 5636896 A AU5636896 A AU 5636896A AU 5636896 A AU5636896 A AU 5636896A
Authority
AU
Australia
Prior art keywords
inhibition
intracellular acidification
acidification
intracellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56368/96A
Inventor
Bernard M. Babior
Robert A. Gottlieb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Scripps Research Institute
Original Assignee
Sandoz AG
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Scripps Research Institute filed Critical Sandoz AG
Publication of AU5636896A publication Critical patent/AU5636896A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU56368/96A 1995-05-05 1996-05-03 Inhibition of intracellular acidification Abandoned AU5636896A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43556195A 1995-05-05 1995-05-05
PCT/US1996/006227 WO1996034604A1 (en) 1995-05-05 1996-05-03 Inhibition of intracellular acidification
US435561 1999-11-08

Publications (1)

Publication Number Publication Date
AU5636896A true AU5636896A (en) 1996-11-21

Family

ID=23728897

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56368/96A Abandoned AU5636896A (en) 1995-05-05 1996-05-03 Inhibition of intracellular acidification

Country Status (2)

Country Link
AU (1) AU5636896A (en)
WO (1) WO1996034604A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10338658A (en) * 1997-04-08 1998-12-22 Hoechst Marion Roussel Kk Retinoid action controller
AU2002228970A1 (en) * 2000-12-11 2002-06-24 The Regents Of The University Of Michigan Treatment of cystic fibrosis with alkalinizing agents
DE102008001811A1 (en) * 2008-05-15 2009-11-19 Beiersdorf Ag Cosmetic preparations for reducing sweat odor with ABCC modulators
US20100081954A1 (en) * 2008-09-30 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method, device, and system to control pH in pulmonary tissue of a subject
WO2012045451A1 (en) 2010-10-05 2012-04-12 Ludwig-Maximilians-Universitaet Muenchen Novel therapeutic treatment of progranulin-dependent diseases
US20150160246A1 (en) 2013-12-11 2015-06-11 Analiza, Inc. Devices and methods for determining and/or isolating cells such as circulating cancer or fetal cells
US9709556B2 (en) 2013-12-11 2017-07-18 Analiza, Inc. Devices and methods for determining and/or isolating circulating cancer cells
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Also Published As

Publication number Publication date
WO1996034604A1 (en) 1996-11-07

Similar Documents

Publication Publication Date Title
AU2730195A (en) Walking aid
AU5579996A (en) Decorative formation of tissue
AU4786496A (en) New forms of paroxetin hydrochloride
AU6614696A (en) Inhibition of gene expression
AU6614596A (en) Inhibition of gene expression
AU6658896A (en) Dehydration of primary alcohols
AU7456396A (en) Inhibition of amyloidosis by 9-acridinones
AU4329396A (en) Use of 3,4-diphenylchromans
AU4788396A (en) Inhibition of angiogenesis using interleukin-12
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU4479096A (en) 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2
AU2332197A (en) Inhibition of intracellular signal transduction by 14-3-3-binding peptides
AU5636896A (en) Inhibition of intracellular acidification
AU7664296A (en) Naphthylazo inhibition of amyloidosis
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU7312196A (en) Synthesis of polymerisable phosphodiesters
AU1703799A (en) Cyclooxygenase-2 inhibition
AU1278897A (en) Passification of zinc surfaces
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU5440596A (en) Inhibiting degradation of a degron-bearing protein
AU6667196A (en) Determination of chromium
AU4634096A (en) Isoxazole derivatives
AU5033296A (en) Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines
AU5126298A (en) Inhibition of crib-biting
AU4446396A (en) Use of dihydroxyacetone